The antiphospholipid triangle

Journal of Thrombosis and Haemostasis

Volumn 8, Issue 2, 2010, Pages 221-227

  Galli, M ^a  

^a OSPEDALI RIUNITI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; EPITOPE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; WARFARIN;

ANTIBODY DETECTION; ANTIBODY TITER; ANTICOAGULANT THERAPY; ANTIGEN RECOGNITION; ANTIPHOSPHOLIPID SYNDROME; ARTERY THROMBOSIS; BLEEDING; HUMAN; INCIDENCE; NOTE; PREGNANCY COMPLICATION; PRIORITY JOURNAL; THROMBOSIS;

EID: 74749084290     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2009.03689.x     Document Type: Note

References (20)

1. Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette J-C, Brey R, Derksen R, Harris EN, Hughes GRV, Triplett DA, Khamashta MA. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Arthritis Rheum 1999, 42:1309-11.
2. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RHWM, de Groot PG, Koike T, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos PG, Krilis SA. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006, 4:295-306.
3. Pengo V, Tripodi A, Reber G, Rand JH, Ortel TL, Galli M, De Groot PG. Update of the guidelines for lupus anticoagulant detection. J Thromb Haemost 2009, 7:1737-40.
4. Kaul M, Erkan D, Sammaritano M, Lockshin MD. Assessment of the 2006 revised antiphospholipid syndrome classification criteria. Ann Rheum Dis 2007, 66:927-30.
5. Swadzba J, Iwaniek T, Szczeklik A, Musial J. Revised classification criteria for antiphospholipid syndrome and the thrombotic risk in patients with autoimmune diseases. J Thromb Haemost 2007, 5:1883-9.
6. Tarr T, Lakos G, Bhattoa HP, Shoenfeld Y, Szegedi G, Kiss E. Analysis of risk factors for the development of thrombotic complications in antiphospholipid antibody positive lupus patients. Lupus 2007, 16:39-45.
7. Galli M, Luciani D, Bertolini G, Barbui T. Antiβ2-glycoprotein I, antiprothrombin antibodies and the risk of thrombosis in the antiphospholipid syndrome. Blood 2003, 102:2717-23.
8. Galli M, Luciani D, Bertolini G, Barbui T. Lupus anticoagulants are stronger risk factors of thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood 2003, 101:1827-32.
9. Opatrny L, David M, Khan SR, Shrier I, Rey E. Association between antiphospholipid antibodies and recurrent fetal loss in women without autoimmune diseases: a metaanalysis. J Rheumatol 2006, 33:2214-21.
10. Pengo V, Biasiolo A, Pegoraro C, Cucchini U, Noventa F. Antibody profiles for the diagnosis of antiphospholipid syndrome. Thromb Haemost 2005, 93:1147-52.
11. Ruffatti A, Tonello M, Del Ross T, Cavazzana A, Grava C, Noventa F, Tona F, Iliceto S, Pengo V. Antibody profile and clinical course in primary antiphospholipid syndrome with pregnancy morbidity. Thromb Haemost 2006, 96:337-41.
12. Lee EY, Chang-Keun L, Lee TH, Chung SM, Kim SH, Cho YS, Yoo B, Moon H-B. Does the anti-β2-glycoprotein I antibody provide additional information in patients with thrombosis? Thromb Res 2003, 111:29-32.
13. Male C, Foulon D, Hogendoorn H, Vee P, Silverman E, David M, Mitchel L. Predictive values of persistent versus transient antiphospholipid antibody subtypes for the risk of thrombotic events in pediatric patients with systemic lupus erythematosus. Blood 2005, 106:4152-8.
14. Forastiero R, Martinuzzo M, Pombo G, Puente D, Rossi A, Celebrin L, Bonaccorso S, Aversa L. A prospective study of antibodies to β2-GPI and prothrombin and risk of thrombosis. J Thromb Haemost 2005, 3:1231-8.
15. Pengo V, Ruffatti A, Legnani C, Gresele P, Barcellona D, Erba N, Testa S, Marongiu F, Bison E, Denas G, Banzato A, Padayattil Jose S, Iliceto S. Clinical course of high risk patients diagnosed with antiphospholipid syndrome (APS). J Thromb Haemost 2010, 8:237-42.
16. Schulman S, Beyth RJ, Kearon C, Levine MN. Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest 2008, 6(Suppl.):257S-98S.
17. de Laat B, Derksen RHWM, Urbanus RT, de Groot PG. IgG antibodies that recognize epitope Gly40-Arg43 in domain I of β2-glycoprotein I cause LAC, and their presence correlates strongly with thrombosis. Blood 2005, 105:1540-5.
18. De Laat HB, Derksen RHWM, Urbanus RT, Roest M, de Groot PG. β2-glycoprotein I-dependent lupus anticoagulant highly correlates with thrombosis in the antiphospholipid syndrome. Blood 2004, 104:3598-602.
19. De Laat HB, Derksen RHWM, van Lummel M, Pennings MTT, de Groot PG. Pathogenic anti-β2-glycoprotein I antibodies recognize β2-glycoprotein I only after a conformational change. Blood 2006, 107:1916-24.
20. de Laat B, Pengo V, Pabinger I, Musial J, Voskuyl AE, Bultink IE, Ruffatti A, Rozman B, Kveder T, de Moerloose P, Boehlen F, Rand J, Ulcova-Gallova Z, Mertens K, de Groot PG. The association between circulating antibodies against domain I of β2-glycoprotein I and thrombosis: an international multicenter study. J Thromb Haemost 2009, 7:1767-73.